New discovery could help prevent the formation of infectious bacterial films on hospital equipment
Bacteria are best known as free-living single cells, but in reality their lives are much more complex. To survive in harsh environments, many species of bacteria will band together and form a biofilm–a collection of cells held together by a tough web of fibers that offers protection from all manner of threats, including antibiotics. A familiar biofilm is the dental plaque that forms on teeth between brushings, but biofilms can form almost anywhere given the right conditions.
Biofilms are a huge problem in the health care industry. When disease-causing bacteria establish a biofilm on sensitive equipment, it can be impossible to sterilize the devices, raising rates of infection and necessitating expensive replacements. So researchers look for ways to break down the defenses of biofilms to prevent them from establishing a foothold.
Now, a University of Maryland-led team has found an important link in the biofilm formation process: an enzyme that shuts down the signals that bacteria use to form a biofilm. The findings, reported in the August 24, 2015 Early Online Edition of the Proceedings of the National Academy of Sciences, have far-reaching implications for the development of new treatments, and could one day help make biofilm-related complications a distant memory.
“Bacteria form biofilms because they sense a change in their environment. They do this by generating a signaling molecule, which binds to a receptor that turns on the response,” said Mona Orr, the lead author of the study and a UMD biological sciences graduate student. “But you need a way to turn off the switch–to remove the signal when it’s no longer needed. We’ve identified the enzyme that completes the process of turning off the switch.”
The well-known switch that activates biofilm formation is a signaling molecule called Cyclic-di-GMP, also known as c-di-GMP. Many species of disease-causing bacteria use c-di-GMP to signal the formation of biofilms, including Escherichia coli, Salmonella enterica and Vibrio cholerae.
But Orr and her colleagues are the first to identify the molecule that completes the process of clearing c-di-GMP from the cell, thus ending the biofilm signaling process. The molecule is an enzyme called oligoribonuclease, and much like c-di-GMP, oligoribonuclease is also common among disease-causing bacterial species.
The team studied the process in the bacteria Pseudomonas aeruginosa, a common species known to cause infections in hospital patients. But because of the genetic and physiological similarities between P. aeruginosa and other infectious species, the researchers believe that oligoribonuclease serves the same function across a wide variety of bacteria.
“You can think of this process in terms of water filling a sink. The rate of water from the faucet is just as important as the size of the drain in determining the level of water in the sink,” said Vincent Lee, a co-author of the study and an associate professor in the UMD Department of Cell Biology and Molecular Genetics and the Maryland Pathogen Research Institute. “The level of c-di-GMP in the cell is analogous to the amount of water in the sink. Because no one knew what the drain was, our findings create a complete picture of the signaling process.”
Orr, Lee and their colleagues from the UMD Department of Chemistry and Biochemistry and Michigan State University focused their work on P. aeruginosa because it is well studied and can survive under a variety of conditions, making it notoriously difficult to control. Contact lens wearers might already be familiar with P. aeruginosa, as it commonly forms infectious, green-tinted biofilms on older lenses or those that have not been cleaned properly.
The team found that oligoribonuclease is necessary for the second of a two-step process. The first, which converts c-di-GMP into an intermediate molecule called pGpG, was already known. Orr, Lee and their colleagues have now filled in the important second step in this process: oligoribonuclease breaks apart pGpG and thus completely shuts off the signaling pathway.
The result suggests that oligoribonuclease could be used to help design new antibiotics, disinfectants, and surface treatments to control biofilms. Such measures could prevent infections and preclude the need for frequent replacement of expensive hospital equipment. Because biofilms can also form on implanted medical devices, such as pacemakers and synthetic joints, effective treatments against biofilms could eliminate the need for costly and risky replacement surgeries.
The Latest on: Biofilm
via Google News
The Latest on: Biofilm
- Kane Biotech Receives New Funding from CanExport SMEs Programon June 24, 2020 at 5:15 am
Kane Biotech Inc. (TSXV:KNE, OTCQB:KNBIF) (the "Company" or "Kane Biotech") today announced that it has been approved ...
- Biofilm-Associated Infectionson June 23, 2020 at 5:00 pm
 Therapeutic approaches using biofilm matrix-degrading enzymes aim to inhibit or reduce the cell-to-cell and cell-to-surface associations during the development of biofilms, detach the ...
- Catheter-Related Infections: It's All About Biofilmon June 22, 2020 at 5:00 pm
The biofilm allows the micro-organisms to adhere to any surface, living or nonliving. The adaptive and genetic changes of the micro-organisms within the biofilm make them resistant to all known ...
- Clarkson’s Dr. Dana Barry Publishes Her Work during the COVID-19 Pandemicon June 22, 2020 at 7:30 am
In addition, Dr. Barry is preparing a manuscript called Teaching during the COVID-19 Pandemic. The titles of the three accepted papers are provided. Active Learning Classes (in KOSEN Colleges of Japan ...
- Kane Biotech Reports Positive Results from Anti-Biofilm Shampoo Consumer Product Teston June 19, 2020 at 1:49 pm
Before it's here, it's on the Bloomberg Terminal.
- Bacterial 'Death Stars' could be tricked into destroying themselveson June 19, 2020 at 5:35 am
Researchers have discovered a network of channels inside bacterial communities which could be used to kill bacteria more quickly by 'tricking' them into transporting drugs.
- Kane Biotech Receives $2.7 Million USD United States Department of Defense Award for DispersinB®on June 18, 2020 at 12:04 pm
Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced that, further to its press releases of January.
- Researchers solve structure of key enzyme critical for biofilm formation in fungal pathogenon June 16, 2020 at 5:00 pm
In a recent paper published in Nature Communications, GlycoNet researchers Dr. Lynne Howell from The Hospital for Sick Children and Dr. Don Sheppard from McGill University solved the structure of a ...
- Engineered Surface Inhibits Biofilm Formationon June 13, 2020 at 5:00 pm
Active agents can be surface-grafted to produce additional bioresponses. In-house tests have shown that Sharklet is effective at inhibiting biofilm formation for up to 21 days. In contrast, formation ...
- Biofilm dispersionon June 12, 2020 at 10:24 am
During dispersion, the final step of the biofilm life cycle, single cells egress from the biofilm to resume a planktonic lifestyle. As the planktonic state is considered to be more vulnerable to ...
via Bing News